AI Verdict
RYAN has stronger fundamentals based on our AI analysis.
RYTM vs RYAN Fundamental Comparison
| Metric | RYTM | RYAN |
|---|---|---|
| Revenue | $189.8M | $3.1B |
| Net Income | $-196.5M | $63.4M |
| Net Margin | -103.6% | 2.1% |
| ROE | -141.3% | 9.8% |
| ROA | -40.9% | 0.6% |
| Current Ratio | 4.41x | 0.98x |
| Debt/Equity | 0.73x | 5.16x |
| EPS | $-3.11 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RYTM vs RYAN: Frequently Asked Questions
Is RYTM or RYAN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RYAN has stronger fundamentals. RYTM is rated SELL (78% confidence) while RYAN is rated HOLD (72% confidence). This is not investment advice.
How does RYTM compare to RYAN fundamentally?
RHYTHM PHARMACEUTICALS, INC. has ROE of -141.3% vs RYAN SPECIALTY HOLDINGS, INC.'s 9.8%. Net margins are -103.6% vs 2.1% respectively.
Which stock pays higher dividends, RYTM or RYAN?
RYTM has a dividend yield of N/A or no dividend while RYAN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RYTM or RYAN for long term?
For long-term investing, consider that RYTM has SELL rating with 78% confidence, while RYAN has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RYTM vs RYAN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RYTM vs RYAN, the AI consensus favors RYAN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.